Apellis Pharmaceuticals, Inc. Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • Apellis Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -29.2 %, a 58.2% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Return On Assets for 2023 was -60.4 %, a 12.5% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Return On Assets for 2022 was -69 %, a 32.6% increase from 2021.
  • Apellis Pharmaceuticals, Inc. annual Return On Assets for 2021 was -102 %, a 144% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -60.4 +8.6 +12.5% Jan 1, 2023 Dec 31, 2023
2022 -69 +33.3 +32.6% Jan 1, 2022 Dec 31, 2022
2021 -102 -60.4 -144% Jan 1, 2021 Dec 31, 2021
2020 -42 +39.8 +48.7% Jan 1, 2020 Dec 31, 2020
2019 -81.8 -23.3 -39.9% Jan 1, 2019 Dec 31, 2019
2018 -58.4 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.